利益相关者对创新的私人药房分销道的看法以及对赞比亚药品质量的影响:质量研究
Scott Kaba Matafwali1, Virginia Bond2,3, Sian E Clarke4
1Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK. esco1789@gmail.com.
Global health, science and practice
|February 27, 2026
概括
赞比亚的创新药房服务面临着与传统系统相似的挑战,需要平衡关注技术,监管和当地环境,以改善药物获取和质量.
科学领域:
- 制药科学 制药科学
- 卫生系统研究 卫生系统研究
- 供应链管理 供应链管理
背景情况:
- 创新的私人药店分销道 (配送服务,电药,电子药店) 显示出改善赞比亚药品获取的前景.
- 关于这些创新道对药品质量和安全的影响的证据有限.
- 本研究探讨了利益相关者对创新的药房道及其对赞比亚药品质量保证和分销的影响的观点.
研究的目的:
- 对赞比亚创新的药房分销道进行全面调查,了解利益相关者的观点.
- 检查这些道对药品质量保证和分销的影响.
- 通过创新的药房服务,确定改善药品获取的挑战和机会.
主要方法:
- 定性研究采用药品供应链中15个主要利益相关者的有目的抽样.
- 进行半结构面试,直到数据和为止.
- 对记录的采访数据进行了自下而上的专题分析.
主要成果:
- 确定了四个相互关联的主题:当前的供应链挑战,创新方法的潜在好处,局限性和缺陷以及建议.
- 当前的挑战包括可负担性,运输和影响所有药房服务的监管限制.
- 创新方法提供了潜在的好处,如增强可追溯性和质量保证,但面临技术和行为障碍.
结论:
- 赞比亚传统药房系统的现有监管和结构问题限制了创新的药房分销方法.
- 成功实施需要平衡技术进步,监管合规性和当地环境.
- 调查结果为决策者提供了可行的指导,以加强药物分发和改善资源有限的环境中的医疗保健服务.
相关概念视频
01:19Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
01:19Factors Affecting Drug Distribution: Miscellaneous Factors
1.1K
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
1.1K
01:26Pharmaceutical Poisoning: Potential Scenarios
39
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
39
01:03Drug Control Governance: Regulatory Bodies and Their Impact
615
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
615
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
387
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
217
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
217